Insider · CIK 0001054942

APPLE ROBERT F

Reports to the SEC for 3 companies · SYDNEY, NSW

sec.gov

Transactions

Companies

Filings

CIK

0001054942

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-08	KZIAKAZIA THERAPEUTICS LTD · Employee Stock Option (right to buy)A Award	Director	AAward	+75K sh	—	—	75,000
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−777K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−56.3K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−592K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−21.7K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−774K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−567K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−475K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−374K sh	$5.60	−$2.09M	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−1.88M sh	$5.60	−$10.5M	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−289K sh	—	—	0
2022-05-24	ANTARES PHARMA, INC.D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−612K sh	$5.60	−$3.43M	0
2022-05-24	ANTARES PHARMA, INC.Stock Option (right to buy)D Disposition to Issuer	Director, President and CEO	DDisposition to Issuer	−726K sh	—	—	0
2022-03-03	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+86.8K sh	—	—	2,526,055
2022-03-03	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−37.7K sh	$3.80	−$143K	2,488,360
2022-02-16	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+76.9K sh	—	—	2,473,523
2022-02-16	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−34.3K sh	$3.66	−$125K	2,439,241
2021-06-13	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−40.9K sh	$4.45	−$182K	2,396,630
2021-06-11	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−58.3K sh	$4.45	−$260K	2,437,522
2021-06-10	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+475K sh	—	—	474,629
2021-06-10	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+249K sh	$4.42	+$1.1M	2,495,839
2021-06-08	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−44.2K sh	$4.39	−$194K	2,246,970
2021-03-01	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−66.3K sh	$4.50	−$298K	2,291,193
2021-03-01	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+153K sh	—	—	2,357,523
2021-02-18	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−250K sh	—	—	0
2021-02-18	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−242K sh	$5.00	−$1.21M	2,204,760
2021-02-18	ANTARES PHARMA, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+250K sh	$0.88	+$220K	2,696,720
2021-02-18	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−232K sh	$5.00	−$1.16M	2,464,564
2021-02-18	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−17.8K sh	$5.01	−$89.4K	2,446,720
2021-02-17	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−116K sh	$4.73	−$550K	2,446,720
2021-02-17	ANTARES PHARMA, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+5,519 sh	$2.62	+$14.5K	2,452,239
2021-02-17	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−5,519 sh	$4.75	−$26.2K	2,446,720
2021-02-17	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−5,519 sh	—	—	0
2021-02-17	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+268K sh	—	—	2,563,033
2021-02-10	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−7,278 sh	—	—	0
2021-02-10	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−7,278 sh	$4.75	−$34.6K	2,295,155
2021-02-10	ANTARES PHARMA, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+7,278 sh	$2.62	+$19.1K	2,302,433
2021-02-09	ANTARES PHARMA, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+49.1K sh	$2.62	+$129K	2,344,284
2021-02-09	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−49.1K sh	—	—	0
2021-02-09	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−49.1K sh	$4.75	−$233K	2,295,155
2021-02-08	ANTARES PHARMA, INC.S Sale	Director, President and CEO	SSale	−33.6K sh	$4.75	−$159K	2,295,155
2021-02-08	ANTARES PHARMA, INC.Stock Option (right to buy)M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	−33.6K sh	—	—	0
2021-02-08	ANTARES PHARMA, INC.M Exercise/Conversion	Director, President and CEO	MExercise/Conversion	+33.6K sh	$2.62	+$88K	2,328,729
2020-06-13	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−40.9K sh	$2.78	−$114K	2,295,155
2020-06-11	ANTARES PHARMA, INC.Stock Option (right to buy)A Award	Director, President and CEO	AAward	+777K sh	—	—	776,617
2020-06-11	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+403K sh	$2.73	+$1.1M	2,336,047
2020-06-08	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−44.2K sh	$3.13	−$138K	1,933,117
2020-06-07	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−48.9K sh	$3.12	−$153K	1,977,340
2020-02-19	ANTARES PHARMA, INC.A Award	Director, President and CEO	AAward	+211K sh	—	—	2,116,673
2020-02-19	ANTARES PHARMA, INC.F Tax Payment	Director, President and CEO	FTax Payment	−90.4K sh	$3.53	−$319K	2,026,276

Recent filings

Accepted (ET)
Jul 84
APPLE ROBERT F0001213900-26-076426
SEC(opens sec.gov)
May 264
APPLE ROBERT F0000899243-22-019783
SEC(opens sec.gov)
Mar 44
APPLE ROBERT F0001016169-22-000035
SEC(opens sec.gov)
Feb 184
APPLE ROBERT F0001016169-22-000012
SEC(opens sec.gov)
Jun 144
APPLE ROBERT F0001209191-21-040326
SEC(opens sec.gov)

Companies

Address

THREE INTERNATIONAL TOWERS, LEVEL 24 300 BARANGAROO AVENUE

SYDNEY, NSW, 2000